SSE: 600062
Announcement on Progress in Major Asset RestructuringThe abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
(600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Progress in Major Asset Restructuring
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
View original source (Shanghai Stock Exchange)
Earlier from China Resources Double-crane Pharmaceutical Co., Ltd. Class A
- "China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Propranolol Hydrochloride Injection of the Wholly-owned Subsidiary China Resources Zizhu Pharmaceutical Co., Ltd. Passing the Consistency Evaluation of Quality and Efficacy for Generic Drugs
- "China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Ezetimibe and Atorvastatin Calcium Tablets by the Wholly-owned Subsidiary China Resources Saike Pharmaceutical Co., Ltd.
- "China Resources Double-Crane Pharmaceutical Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
- "China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Lomustine Capsules